RETRACTION: Long Noncoding RNA SNHG15 Serves as an Oncogene and Predicts Poor Prognosis in Epithelial Ovarian Cancer (Retraction of Vol 13, Pg 6747, 2020)

被引：0

作者：

不详

机构：

来源：

ONCOTARGETS AND THERAPY | 2023年 / 16卷

关键词：

D O I：

10.2147/OTT.S432310

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：647 / 647

页数：1

共 50 条

[41] RETRACTION: Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs (Retraction of Vol 13, Pg 6755, 2020)
Sun, F.
Wu, K.
Yao, Z.
ONCOTARGETS AND THERAPY, 2023, 16 : 745 - 745
[42] RETRACTION: Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells (Retraction of Vol 13, Pg 9419, 2020)
Ren, F.
Shrestha, C.
Shi, H.
ONCOTARGETS AND THERAPY, 2024, 17 : 359 - 359
[43] RETRACTION: Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer (Retraction of Vol 19, Pg 1186, 2020)
Gao, Hong
Sun, Xiaosong
Wang, Hongdong
Zheng, Ying
CELL CYCLE, 2021, 20 (24) : 2667 - 2667
[44] RETRACTION: Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating miR-101-3p/STC1 Axis (Retraction of Vol 13, Pg 3653, 2020)
Luan, C.
Li, Y.
Liu, Z.
Zhao, C.
ONCOTARGETS AND THERAPY, 2023, 16 : 651 - 651
[45] RETRACTION: Long Noncoding RNA ST7-AS1 Upregulates TRPM7 Expression by Sponging microRNA-543 to Promote Cervical Cancer Progression (Retraction of Vol 13, Pg 7257, 2020)
Qi, H.
Lu, L.
Wang, L.
ONCOTARGETS AND THERAPY, 2023, 16 : 581 - 581
[46] RETRACTION: Long noncoding RNA SNHG14 contributes to gastric cancer development through targeting miR-145/SOX9 axis (Retraction of Vol 2018, Pg 6905, 2018)
Liu, Zhao
Yan, Yan
Cao, Sizhe
Chen, Yi
JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 (01) : 149 - 149
[47] Retraction Note: Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma
T. Li
J. Xie
C. Shen
D. Cheng
Y. Shi
Z. Wu
X. Deng
H. Chen
B. Shen
C. Peng
H. Li
Q. Zhan
Z. Zhu
Oncogene, 2022, 41 : 4839 - 4839
[48] RETRACTION: Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9 (Retraction of Vol 24, Pg 10375, 2020)
LIU, Z. -H.
LIU, W. -J.
YU, X. -Y.
QI, X. -L.
SUN, C. -C.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (11) : 3798 - 3798
[49] RETRACTION: Statement of Retraction: Upregulation of oxidative stress-responsive 1(OXSR1) predicts poor prognosis and promotes hepatocellular carcinoma progression (Retraction of Vol 11, Pg 958, 2020)
Chen, Jianhui
Zhou, Jiangfan
Fu, Haotian
Ni, Xiaofeng
Shan, Yufeng
BIOENGINEERED, 2021, 12 (01) : 1698 - 1698
[50] RETRACTION: Silencing the long noncoding RNA, TINCR, a molecular sponge of miR-335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression (Retraction of Vol 55, Pg 1110, 2019)
Li, Rui
Wang, Yue
Xu, Yuexun
He, Xiaoli
Li, Yali
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 61 (04)

← 1 2 3 4 5 →